Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
08/2010
08/18/2010CN101804061A New methylprednisolone tablets and crystal form and preparation method thereof
08/18/2010CN101804058A Medicament for preventing mammitis of dairy cattle during nonlactating and preparation method thereof
08/18/2010CN101804054A Application, preparation and preparation method of synthetic palmatine
08/18/2010CN101804041A Controlled release compositions comprising nimesulide
08/18/2010CN101804040A Ketoprofen slow-release orally disintegrating tablets
08/18/2010CN101804030A Sodium dichlorophenolate micro-pill pharmaceutical preparation and preparation method thereof
08/18/2010CN101804022A Gel taking 2alpha, 3beta, 12,13-tetrahydroxy-oleanane-28-acid as active component
08/18/2010CN101803531A China cryptoporus sinensis and solid cultural method and application thereof
08/18/2010CN101348516B Refining process of triamcinolone acetonide raw medicine
08/18/2010CN101244135B Medicine label for treating rheumatism, hyperosteogeny
08/18/2010CN101077403B Plaster for treating retention of food and dysmenorrhea
08/18/2010CN101024029B Medicine for treating bony arthritis, rheumatism arthritis
08/17/2010US7777057 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
08/17/2010US7777050 N3 alkylated benzimidazole derivatives as MEK inhibitors
08/17/2010US7776919 modulators of the interaction between the receptor for advanced glycated end products; 3-(4-Benzyloxyphenyl)propionic Acid 2,4- Di-(3-Diethylamino-1-propoxy)aniline Amide; acute and chronic inflammation; diabetic late complications; Alzheimer's disease, erectile dysfunction; metastasis
08/17/2010US7776902 N-[4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenylsulfonyl]-4-nitrooxybutanamide, used for the treatment of inflammatory, cardiovascular, gastrointestinal, respiratory and nervous system disorders, as analgesics, antipyretics and antocoagulants or for organ and tissue preservation
08/17/2010US7776898 Opioid receptor active compounds
08/17/2010US7776890 1H-indazole compounds
08/17/2010US7776861 Cycloheteroalkenyl compounds used as analgesics and for treating incontinence, inflammatory bowel disease, Parkinson's disease, amyotrophic lateral sclerosis, dementia, epilepsy, retinopathy, pruritus, psychoses, Huntington's disease, headaches, vomiting, dyskinesia or as anxiolytics and antidepressants
08/17/2010US7776846 Administering a synergistic mixture of a cortisone, hydrocortisone and/or prednisolone derivative; antiasthmatic agents; side effect reduction
08/17/2010US7776829 lupus; for patients who are refractory or intractable to corticosteroid treatment, and treatment with cyclophosphamide, azathioprine, mycophenolate mofetil, anti-thymocyte-globin, methotrexate and immunoglobulin
08/17/2010US7775469 treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject; isolating a stromal-cell-derived fugetactic agent
08/17/2010CA2562104C Crystalline pyrazole derivative
08/17/2010CA2547591C Novel compounds and compositions as cathepsin inhibitors
08/17/2010CA2527203C Casr antagonist
08/17/2010CA2461963C Cyclic amine compounds
08/17/2010CA2461212C Diaryl sulfide derivatives, salts thereof and immunosuppressive agents using the same
08/17/2010CA2431974C Urea and urethane derivatives as integrin inhibitors
08/17/2010CA2411436C A method for detecting protein inhibitors and ligands
08/17/2010CA2403086C Apoptosis inhibiting composition comprising a 15-keto-prostaglandin or derivative thereof
08/17/2010CA2385269C Novel thiazolo(4,5-d)pyrimidine compounds
08/17/2010CA2337828C Phosphinic and phosphonic acid derivatives used as pharmaceuticals
08/17/2010CA2290742C Use of galt-2 inhibitor compounds to treat conditions associated with lactosylceramide
08/12/2010WO2010090716A1 Heteroaryls and their use as pi3k inhibitors
08/12/2010WO2010090272A1 Remedy for chronic inflammation and antibody to be used therein
08/12/2010WO2010089510A2 Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof
08/12/2010WO2010089379A1 Method and means for producing tissues and tissues obtained
08/12/2010WO2010089084A1 Substituted indole compounds as bradykinin receptor 1 modulators
08/12/2010WO2010088786A1 Herbal composition having cox-2 and immune activities and preparation method thereof
08/12/2010WO2010054126A3 Small molecule modulators of epigenetic regulation and their therapeutic applications
08/12/2010WO2010054015A3 Methods of reducing the risk of cardiovascular disease in postmenopausal women
08/12/2010WO2009130600A8 Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy
08/12/2010US20100204275 N-piperidin-4-ylmethyl-amide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
08/12/2010US20100204274 Piperidinyl derivatives as modulators of chemokine receptor activity
08/12/2010US20100204255 Bicyclic derivatives as modulators of ion channels
08/12/2010US20100204225 Organic compounds
08/12/2010US20100204213 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
08/12/2010US20100204212 Fused heterocyclic compounds useful as kinase modulators
08/12/2010US20100204208 Protein kinase c inhibitors and uses thereof
08/12/2010US20100204203 Chemical Compounds 637: Pyridopyrimidinediones as PDE4 Inhibitors
08/12/2010US20100204188 Method of synergistically enhancing the therapeutic efficacy and safety of medications through a combination therapy
08/12/2010US20100204184 Phosphonates useful as modulators of T-gamma-9-delta-2 activity
08/12/2010US20100204182 Ectonucleotidase inhibitors
08/12/2010US20100204179 Resveratrol complex and process for the preperation
08/12/2010US20100204170 Heterobifunctional pan-selectin inhibitors
08/12/2010US20100204155 Use of the peptide sfllr-oh and muramyl dipeptide as therapeutic agents
08/12/2010US20100204154 Use of the peptide rfmwmr as a therapeutic agent
08/12/2010US20100204150 Use of a peptide as a therapeutic agent
08/12/2010US20100204143 Gamma 1 msh alone or in combination with pentagastrin as a therapeutic agent
08/12/2010US20100204141 Use of bpp-b as a therapeutic agent
08/12/2010US20100204139 Use of gonadorelin as a therapeutic agent
08/12/2010US20100204136 Use of a peptide as a therapeutic agent
08/12/2010US20100204134 Use of the peptide his-ser-leu-gly-lys-trp-leu-gly-his-pro-asp-lys-phe alone or in combination with the peptide gly-ard-gly-asp-asn-pro-oh as a therapeutic agent
08/12/2010US20100204132 THERAPEUTIC USES OF PEPTIDES YSAYPDSVPMMS and WMNSTGFTKVCGAPPC
08/12/2010US20100204124 Compositions and Methods for Minimally-Invasive Systemic Delivery of Proteins Including TGF-Beta Superfamily Members
08/12/2010US20100204114 Use of a galanin peptide as a therapeutic agent
08/12/2010US20100204113 Use of stresscopin-related peptide as a therapeutic agent
08/12/2010US20100204112 Use of tyr-w-mif-1 and urocortin 2 as therapeutic agents
08/12/2010US20100204110 Use of a peptide as a therapeutic agent
08/12/2010US20100204096 Treatment of inflammation, demyelination and neuronal/axonal loss
08/12/2010US20100203628 Novel modified galectin 9 proteins and use thereof
08/12/2010US20100203542 Method for treating autoimmune diseases and screening method for preventive or therapeutic agent for the same
08/12/2010US20100203177 Use of anabolic agents, anti-catabolic agents, antioxidant agents and analgesics for protection, treatment and repair of connective tissues in humans and animals
08/12/2010US20100203153 Sustained-release nanoparticle compositions and methods using the same
08/12/2010US20100203145 Continuous process for microspheres production by using expanded fluids
08/12/2010US20100203087 Chemorepulsion of cells
08/12/2010US20100203084 Method for treating pain or opioid dependence using a specific type of non-opioid agent in combination with a selective excitatory-opioid-receptor inactivator
08/12/2010US20100203078 Anti-obese compositions containing holoptelea integrifolia extracts
08/12/2010US20100203052 Binding domain-immunoglobulin fusion proteins
08/12/2010US20100203051 Diagnostic markers for ankylosing spondylitis and uses thereof
08/12/2010US20100203042 Recombinant anti-vla4 antibody molecules
08/12/2010US20100203039 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
08/12/2010US20100203011 Mammalian Cytokines; Related Reagents and Methods
08/12/2010US20100203008 Novel compositions for the treatment of verious inflammatory conditions
08/12/2010US20100202982 Oral Composition Containing Interferon-Alpha
08/12/2010US20100202967 Fibrin binding pepetide conjugates for diagnostic and therapeutic applications
08/12/2010CA2751481A1 Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof
08/12/2010CA2751402A1 Substituted indole compounds as bradykinin receptor 1 modulators
08/12/2010CA2750935A1 Heteroaryls and their use as pi3k inhibitors
08/11/2010EP2216409A1 Albumin fusion proteins
08/11/2010EP2216404A1 Method of producing an antibody using a cell in which the function of fucose transporter is inhibited
08/11/2010EP2216318A2 Resolvins: Biotemplates for therapeutic interventions
08/11/2010EP2215094A1 N-containing heterocyclic compounds
08/11/2010EP2215089A1 [1h- pyrazolo [3, 4-b]pyridine-4-yl]-phenyle or -pyridin-2-yle derivatives as protein kinase c-theta
08/11/2010EP2215082A1 Phthalazine and pyrido ý3,4-d¨pyridaz ine compounds as h1 receptor antagonists
08/11/2010EP2215080A1 Diazepane compounds which modulate the cb2 receptor
08/11/2010EP2215061A2 Trpv1 antagonists
08/11/2010EP2215059A2 Novel heteroaryl-substituted acetone derivative, suitable for inhibiting phospholipase a2
08/11/2010EP2215055A1 New non-peptide derivatives as bradykinin b1 antagonists
08/11/2010EP2214696A1 Methods of treating chronic neurogenic inflammation using modified clostridial toxins
1 ... 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 ... 1272